Contrast ultrasound for uncertain ovarian lesions
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether a special ultrasound using a contrast agent can better tell if an ovarian lesion is benign or malignant. The goal is to help doctors make more accurate decisions without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are able to make your own treatment decisions.
- You have an ovarian or nearby lesion that is rated as O-RADS 3, 4, or 5 (meaning it's not clearly benign and needs more testing).
- The lesion is between 1 and 15 centimeters in size.
- You are not pregnant or breastfeeding.
- You do not have any reason that would make the contrast ultrasound unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special ultrasound technique to get better images of ovarian growths before surgery. The goal is to improve detection and help plan the best treatment.
This study uses ultrasound to look at how ovarian cancer affects the liver, helping doctors plan surgery better. By taking detailed pictures of the liver before surgery, they hope to improve outcomes for people with advanced or recurrent ovarian cancer.
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.
This trial is testing an investigational contrast agent (FRD001) to see if it improves ultrasound images of suspicious ovarian masses. The goal is to help doctors better tell if a mass is cancerous or not.
This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.